Wake Up Wall Street (SPY) (QQQ): Microsoft (MSFT) to buy Activision (ATVI) but Goldman (GS) misses
Premium|You have reached your limit of 5 free articles for this month.
Get all exclusive analysis, access our analysis and get Gold and signals alerts
Elevate your trading Journey.
UPGRADEHere is what you need to know on Tuesday, January 18:
Goldman (GS) kept up the disappointing bank season so far when it missed on EPS, while revenue was ahead of estimates. The stock dropped 4% immediately after. This follows on from Citi (C) and JPMorgan (JPM) disappointing investors last week, and bank stocks will slump further today as a result.
Tech stocks looked set for a shaky opening as a yield surge led Nasdaq futures 2% lower at one stage this morning. However, Microsoft (MSFT) coming after Activision Blizzard (ATVI) in an all-cash deal may help to steady the Nasdaq ship slightly and certainly put gaming stocks on the offensive.
The dollar, meanwhile, is a touch stronger this morning at $1.1376 versus the euro. Oil is at $85.47 on supply concerns, and Bitcoin is at $41,400. Yields are higher across the board with the German 10-year nearly reaching positive territory for the first time in three years this morning. Gold is at $1,818.
European markets are lower: Eurostoxx -0.7%, Dax -1% and FTSE -0.6%.
US futures are lower: S&P -15, Dow -0.8% and NASDAQ -1.45.
Wall Street (QQQ) (SPY) Stock News
Microsoft (MSFT) to buy Activision Blizzard (ATVI) in all-cash deal for $95 per share, $69 billion.
Goldman Sachs (GS) falls on a miss in EPS, but revenue beats.
Alibaba (BABA) falls as Reuters report says Biden administration looking into cloud unit.
Dollar General (DG) falls as Morgan Stanley downgrades.
23andMe (ME): GSK exercises option to extend the partnership.
Apple (AAPL): Deutsche Bank raises price target.
GAP falls 5% on Morgan Stanley downgrade.
Credit Suisse (CS) chairman resigns on covid protocol violation reports. Boris johnson take note!!
Unilever (UL) bidding for Glaxo (GSK) consumer health business.
Upgrades and Downgrades
Source: Benzinga Pro
Economic releases
Like this article? Help us with some feedback by answering this survey:
Here is what you need to know on Tuesday, January 18:
Goldman (GS) kept up the disappointing bank season so far when it missed on EPS, while revenue was ahead of estimates. The stock dropped 4% immediately after. This follows on from Citi (C) and JPMorgan (JPM) disappointing investors last week, and bank stocks will slump further today as a result.
Tech stocks looked set for a shaky opening as a yield surge led Nasdaq futures 2% lower at one stage this morning. However, Microsoft (MSFT) coming after Activision Blizzard (ATVI) in an all-cash deal may help to steady the Nasdaq ship slightly and certainly put gaming stocks on the offensive.
The dollar, meanwhile, is a touch stronger this morning at $1.1376 versus the euro. Oil is at $85.47 on supply concerns, and Bitcoin is at $41,400. Yields are higher across the board with the German 10-year nearly reaching positive territory for the first time in three years this morning. Gold is at $1,818.
European markets are lower: Eurostoxx -0.7%, Dax -1% and FTSE -0.6%.
US futures are lower: S&P -15, Dow -0.8% and NASDAQ -1.45.
Wall Street (QQQ) (SPY) Stock News
Microsoft (MSFT) to buy Activision Blizzard (ATVI) in all-cash deal for $95 per share, $69 billion.
Goldman Sachs (GS) falls on a miss in EPS, but revenue beats.
Alibaba (BABA) falls as Reuters report says Biden administration looking into cloud unit.
Dollar General (DG) falls as Morgan Stanley downgrades.
23andMe (ME): GSK exercises option to extend the partnership.
Apple (AAPL): Deutsche Bank raises price target.
GAP falls 5% on Morgan Stanley downgrade.
Credit Suisse (CS) chairman resigns on covid protocol violation reports. Boris johnson take note!!
Unilever (UL) bidding for Glaxo (GSK) consumer health business.
Upgrades and Downgrades
Source: Benzinga Pro
Economic releases
Like this article? Help us with some feedback by answering this survey:
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.